wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36021424-2B7EB0D0-67E9-48C9-9795-30ABE1CED448
Q36021424-2B7EB0D0-67E9-48C9-9795-30ABE1CED448
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36021424-2B7EB0D0-67E9-48C9-9795-30ABE1CED448
Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy.
P2860
Q36021424-2B7EB0D0-67E9-48C9-9795-30ABE1CED448
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36021424-2B7EB0D0-67E9-48C9-9795-30ABE1CED448
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be0df020a9e1ef524c1c93a7898c45c3393b6da5
P2860
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial